Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
Introduction Continuous monitoring is the hallmark of managing chronic disease. Multiple sclerosis (MS), in particular, requires patients to visit their treating neurologists typically twice a year, at least. In that respect, the COVID-19 pandemic made us rethink our communication strategies. This s...
Main Authors: | Patrick Altmann, Fritz Leutmezer, Markus Ponleitner, Dominik Ivkic, Nik Krajnc, Paulus Stefan Rommer, Thomas Berger, Gabriel Bsteh |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-07-01
|
Series: | Digital Health |
Online Access: | https://doi.org/10.1177/20552076221112154 |
Similar Items
-
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial
by: Patrick Altmann, et al.
Published: (2022-11-01) -
Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
by: Patrick Altmann, et al.
Published: (2021-02-01) -
Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
by: Gabriel Bsteh, et al.
Published: (2022-01-01) -
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
by: Nik Krajnc, et al.
Published: (2022-06-01) -
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
by: Altmann, Patrick, et al.
Published: (2021-05-01)